ERBB2 and breast carcinoma: Amplification of ERBB2 oncogene and/or overexpression of HER2protein in breast cancer have been linked to poor prognosis and a differentialresponse to a variety of systemic treatments [11], therefore, HER2 status playsan important role in the prognosis and prediction for breast cancer patients.